XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS'/MEMBERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Effect of Business Combination
IMC
IMC
Effect of Business Combination
SMA
Common Stock
Class A Common Stock
Common Stock
Class A Common Stock
Effect of Business Combination
Common Stock
Class A Common Stock
IMC
Common Stock
Class A Common Stock
IMC
Effect of Business Combination
Common Stock
Class A Common Stock
SMA
Additional Paid-in-Capital
Additional Paid-in-Capital
Effect of Business Combination
Additional Paid-in-Capital
IMC
Additional Paid-in-Capital
IMC
Effect of Business Combination
Additional Paid-in-Capital
SMA
Member's Units
Member's Units
Effect of Business Combination
Member's Equity
Member's Equity
Effect of Business Combination
Retained Earnings (Deficit)
Retained Earnings (Deficit)
Effect of Business Combination
Beginning balance at Dec. 31, 2020 $ 6,727                             $ 223   $ 6,504    
Net loss 11,359                                        
Net loss prior to business combination (5,185)                                 (5,185)      
Reverse recapitalization   $ (186,629)         $ 3         $ (186,632)         $ (223)   $ (1,319)   $ 1,542
Reverse recapitalization (in shares)             28,780,819                            
Equity consideration issued to acquire company     $ 5,027 $ 155,347         $ 1       $ 5,027 $ 155,346              
Equity consideration issued to acquire company (in shares)               384,615 10,412,023                        
Shares issued for holdback   821                   821                  
Shares issued for holdback (in shares)             55,000                            
Proceeds from the sale of Class A common stock, net of offering costs   397,529         $ 4         397,525                  
Proceeds from the sale of Class A common stock, net of offering costs (in shares)             41,000,000                            
Net income after business combination 16,543                                        
Ending balance at Jun. 30, 2021 390,181         $ 8         $ 372,088                 18,085  
Ending balance (in shares) at Jun. 30, 2021           80,632,457                              
Beginning balance at Mar. 31, 2021 8,029                             $ 223   7,805      
Net loss 10,057                                        
Net loss prior to business combination (6,487)                                 $ (6,487)      
Reverse recapitalization   (186,629)         $ 3         (186,632)         $ (223)   $ (1,319)   $ 1,542
Reverse recapitalization (in shares)             28,780,819                            
Equity consideration issued to acquire company       $ 155,347 $ 5,027       $ 1         $ 155,346 $ 5,027            
Equity consideration issued to acquire company (in shares)                 10,412,023 384,615                      
Shares issued for holdback   821                   821                  
Shares issued for holdback (in shares)             55,000                            
Proceeds from the sale of Class A common stock, net of offering costs   $ 397,529         $ 4         $ 397,525                  
Proceeds from the sale of Class A common stock, net of offering costs (in shares)             41,000,000                            
Net income after business combination 16,543                                     16,543  
Ending balance at Jun. 30, 2021 390,181         $ 8         372,088                 18,085  
Ending balance (in shares) at Jun. 30, 2021           80,632,457                              
Beginning balance at Dec. 31, 2021 505,370         $ 9         505,327                 33  
Beginning balance (in shares) at Dec. 31, 2021           87,367,972                              
Net loss (26,178)                                     (26,178)  
Stock-based compensation expense 3,875                   3,875                    
Issuance of shares upon vesting of stock-based compensation awards           100,000                              
Vesting of Series B Warrants under Advisory Agreement 5,060                   5,060                    
Ending balance at Jun. 30, 2022 488,127         $ 9         514,262                 (26,144)  
Ending balance (in shares) at Jun. 30, 2022           87,467,972                              
Beginning balance at Mar. 31, 2022 492,190         $ 9         508,945                 (16,763)  
Beginning balance (in shares) at Mar. 31, 2022           87,367,972                              
Net loss (9,381)                                     (9,381)  
Stock-based compensation expense 2,787                   2,787                    
Issuance of shares upon vesting of stock-based compensation awards           100,000                              
Vesting of Series B Warrants under Advisory Agreement 2,530                   2,530                    
Ending balance at Jun. 30, 2022 $ 488,127         $ 9         $ 514,262                 $ (26,144)  
Ending balance (in shares) at Jun. 30, 2022           87,467,972